Close
  Indian J Med Microbiol
 

Figure 3: Clinically significant prostate cancer detection rates stratified by the combination of PI-RADS v2 score, tPSA, and PSAD. Green, yellow, and red zones indicate low-, moderate- and high-risk groups, respectively. PI-RADS v2: Prostate Imaging Reporting and Data System version 2; PSAD: prostate-specific antigen density; tPSA: total prostate-specific antigen.

Figure 3: Clinically significant prostate cancer detection rates stratified by the combination of PI-RADS v2 score, tPSA, and PSAD. Green, yellow, and red zones indicate low-, moderate- and high-risk groups, respectively. PI-RADS v2: Prostate Imaging Reporting and Data System version 2; PSAD: prostate-specific antigen density; tPSA: total prostate-specific antigen.